Sudden death related cardiomyopathies - Hypertrophic cardiomyopathy

被引：14

作者：

Goff, Zackary D. ^{[1
]}

Calkins, Hugh ^{[1
,2
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA

[2] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA

来源：

PROGRESS IN CARDIOVASCULAR DISEASES | 2019年 / 62卷 / 03期

关键词：

Cardiomyopathy; Hypertrophic cardiomyopathy; Sudden cardiac death; RISK PREDICTION MODEL; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; 2014; EUROPEAN-SOCIETY; NONSUSTAINED VENTRICULAR-TACHYCARDIA; LOW CARDIOVASCULAR MORTALITY; ASSOCIATION TASK-FORCE; CARDIAC DEATH; AMERICAN-COLLEGE; CARDIOLOGY GUIDELINES; UNITED-KINGDOM;

D O I：

10.1016/j.pcad.2019.04.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hypertrophic cardiomyopathy (HCM) is a form of inherited cardiomyopathy. Most individuals with HCM experience minimal symptoms throughout their lifetime. However, those with HCM are at risk of ventricular arrhythmias and sudden cardiac death (SCD), the most feared complication of HCM. Implantable cardioverter defibrillator (ICD) implantation has played a large role in transforming this disease from one with an ominous prognosis to one with mortality rates that are on par with the general public. Since the early 2000s, balance between SCD prevention and unnecessary ICD placement has been sought, this is reflected in the evolution of SCD risk stratification models for patients with HCM. This review discusses key concepts pertaining to HCM, with emphasis on prevention of SCD, and summarizes and compares the recommendations for ICD implantation in current guidelines. (C) 2019 Elsevier Inc. All rights reserved.

引用

页码：212 / 216

页数：5

共 52 条

[1] Updated Meta-Analysis of Septal Alcohol Ablation Versus Myectomy for Hypertrophic Cardiomyopathy
Agarwal, Shikhar
Tuzcu, E. Murat
Desai, Milind Y.
Smedira, Nicholas
Lever, Harry M.
Lytle, Bruce W.
Kapadia, Samir R.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (08) : 823 - 834
[2] Al-Khatib Sana M, 2018, J Am Coll Cardiol, V72, pe91, DOI 10.1016/j.jacc.2017.10.054
[3] Genetic basis of hypertrophic cardiomyopathy: From bench to the clinics
Alcalai, Ronny
Seidman, Jonathan G.
Seidman, Christine E.
[J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2008, 19 (01) : 104 - 110
[4] Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR
Avanesov, Maxim
Muench, Julia
Weinrich, Julius
Well, Lennart
Saering, Dennis
Stehning, Christian
Tahir, Enver
Bohnen, Sebastian
Radunski, Ulf K.
Muellerleile, Kai
Adam, Gerhard
Patten, Monica
Lund, Gunnar
[J]. EUROPEAN RADIOLOGY, 2017, 27 (12) : 5136 - 5145
[5] A Prospective Study of Sudden Cardiac Death among Children and Young Adults
Bagnall, R. D.
Weintraub, R. G.
Ingles, J.
Duflou, J.
Yeates, L.
Lam, L.
Davis, A. M.
Thompson, T.
Connell, V.
Wallace, J.
Naylor, C.
Crawford, J.
Love, D. R.
Hallam, L.
White, J.
Lawrence, C.
Lynch, M.
Morgan, N.
James, P.
du Sart, D.
Puranik, R.
Langlois, N.
Vohra, J.
Winship, I.
Atherton, J.
McGaughran, J.
Skinner, J. R.
Semsarian, C.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (25) : 2441 - 2452
[6] Aetiology of sudden cardiac death in athletes in the United Kingdom: a pathological study
de Noronha, S. V.
Sharma, S.
Papadakis, M.
Desai, S.
Whyte, G.
Sheppard, M. N.
[J]. HEART, 2009, 95 (17) : 1409 - 1414
[7] Global longitudinal strain and left atrial volume index improve prediction of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy patients
Debonnaire, Philippe
Thijssen, Joep
Leong, Darryl P.
Joyce, Emer
Katsanos, Spyridon
Hoogslag, Georgette E.
Schalij, Martin J.
Atsma, Douwe E.
Bax, Jeroen J.
Delgado, Victoria
Marsan, Nina Ajmone
[J]. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2014, 30 (03) : 549 - 558
[8] Left Ventricular Outflow Tract Obstruction as a Risk Factor for Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Efthimiadis, Georgios K.
Parcharidou, Despina G.
Giannakoulas, Georgios
Pagourelias, Efstathios D.
Charalampidis, Panagiotis
Savvopoulos, Gregorios
Ziakas, Antonios
Karvounis, Haralambos
Styliadis, Ioannis H.
Parcharidis, Georgios E.
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (05) : 695 - 699
[9] 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
Elliott, Perry M.
Anastasakis, Aris
Borger, Michael A.
Borggrefe, Martin
Cecchi, Franco
Charron, Philippe
Hagege, Albert Alain
Lafont, Antoine
Limongelli, Giuseppe
Mahrholdt, Heiko
McKenna, William J.
Mogensen, Jens
Nihoyannopoulos, Petros
Nistri, Stefano
Pieper, Petronella G.
Pieske, Burkert
Rapezzi, Claudio
Rutten, Frans H.
Tillmanns, Christoph
Watkins, Hugh
[J]. EUROPEAN HEART JOURNAL, 2014, 35 (39) : 2733 - +
[10] 2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
Epstein, Andrew E.
DiMarco, John P.
Ellenbogen, Kenneth A.
Estes, N. A. Mark, III
Freedman, Roger A.
Gettes, Leonard S.
Gillinov, A. Marc
Gregoratos, Gabriel
Hammill, Stephen C.
Hayes, David L.
Hlatky, Mark A.
Newby, L. Kristin
Page, Richard L.
Schoenfeld, Mark H.
Silka, Michael J.
Stevenson, Lynne Warner
Sweeney, Michael O.
Tracy, Cynthia M.
Epstein, Andrew E.
Darbar, Dawood
DiMarco, John P.
Dunbar, Sandra B.
Estes, N. A. Mark, III
Karasik, Pamela E.
Link, Mark S.
Marine, Joseph E.
Schoenfeld, Mark H.
Shanker, Amit J.
Silka, Michael J.
Stevenson, Lynne Warner
Stevenson, William G.
Varosy, Paul D.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (03) : E6 - E75

← 1 2 3 4 5 6 →